Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B cells and their fate in health and disease.
Caligaris-Cappio F, Ferrarini M. Caligaris-Cappio F, et al. Immunol Today. 1996 May;17(5):206-8. doi: 10.1016/0167-5699(96)30008-x. Immunol Today. 1996. PMID: 8991379 Review.
MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S, Fortis C, Belloni D, Ferrero E, Ticozzi P, Sciorati C, Tresoldi M, Vicari A, Spies T, Groh V, Caligaris-Cappio F, Ferrarini M. Girlanda S, et al. Among authors: caligaris cappio f. Cancer Res. 2005 Aug 15;65(16):7502-8. doi: 10.1158/0008-5472.CAN-05-0731. Cancer Res. 2005. PMID: 16103105
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas.
Ferreri AJ, Dell'Oro S, Foppoli M, Bernardi M, Brandes AA, Tosoni A, Montanari M, Balzarotti M, Spina M, Ilariucci F, Zaja F, Stelitano C, Bobbio F, Corazzelli G, Baldini L, Ponzoni M, Picozzi P, Caligaris Cappio F, Reni M. Ferreri AJ, et al. Among authors: caligaris cappio f. Neurology. 2006 May 9;66(9):1435-8. doi: 10.1212/01.wnl.0000210464.94122.e1. Neurology. 2006. PMID: 16682682 Clinical Trial.
Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib.
Nerini-Molteni S, Ferrarini M, Cozza S, Caligaris-Cappio F, Sitia R. Nerini-Molteni S, et al. Among authors: caligaris cappio f. Br J Haematol. 2008 May;141(4):494-503. doi: 10.1111/j.1365-2141.2008.07066.x. Epub 2008 Mar 12. Br J Haematol. 2008. PMID: 18341633 Free article.
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.
Crocchiolo R, Canevari C, Assanelli A, Lunghi F, Tassara M, Stanghellini ML, Clerici D, Landoni C, Servida P, Bernardi M, Peccatori J, Ferreri A, Gianolli L, Bordignon C, Caligaris-Cappio F, Ciceri F, Fazio F. Crocchiolo R, et al. Among authors: caligaris cappio f. Leuk Lymphoma. 2008 Apr;49(4):727-33. doi: 10.1080/10428190701885545. Leuk Lymphoma. 2008. PMID: 18398740
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJ, et al. Among authors: caligaris cappio f. Lancet. 2009 Oct 31;374(9700):1512-20. doi: 10.1016/S0140-6736(09)61416-1. Epub 2009 Sep 18. Lancet. 2009. PMID: 19767089 Free article. Clinical Trial.
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.
Gregorc V, Citterio G, Vitali G, Spreafico A, Scifo P, Borri A, Donadoni G, Rossoni G, Corti A, Caligaris-Cappio F, Del Maschio A, Esposito A, De Cobelli F, Dell'Acqua F, Troysi A, Bruzzi P, Lambiase A, Bordignon C. Gregorc V, et al. Among authors: caligaris cappio f. Eur J Cancer. 2010 Jan;46(1):198-206. doi: 10.1016/j.ejca.2009.10.005. Eur J Cancer. 2010. PMID: 19900802 Clinical Trial.
Bortezomib induces autophagic death in proliferating human endothelial cells.
Belloni D, Veschini L, Foglieni C, Dell'Antonio G, Caligaris-Cappio F, Ferrarini M, Ferrero E. Belloni D, et al. Among authors: caligaris cappio f. Exp Cell Res. 2010 Apr 1;316(6):1010-8. doi: 10.1016/j.yexcr.2009.11.005. Epub 2009 Nov 13. Exp Cell Res. 2010. PMID: 19917281
233 results